Merit Medical (MMSI) CEO Fred Lampropoulos disclosed the sale of 20,000 at an average price of $96.54 for a value of $1.93M. Lampropoulos still owns 1,066,028 shares of Merit Medical.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMSI:
- Positive Outlook for Merit Medical Systems Amid Tariff Reductions and Resilient Growth
- Merit Medical price target raised to $110 from $106 at Piper Sandler
- Merit Medical price target raised to $112 from $108 at Canaccord
- Merit Medical price target raised to $108 from $106 at Wells Fargo
- Merit Medical Acquires Biolife Delaware for $120 Million